Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
2.32 USD | +4.04% | +5.94% | -32.95% |
Mar. 07 | Transcript : Nephros, Inc., Q4 2023 Earnings Call, Mar 07, 2024 | |
Mar. 07 | Nephros, Inc. Reports Earnings Results for the Full Year Ended December 31, 2023 | CI |
Financials (USD)
Sales 2024 * | 16.7M | Sales 2025 * | 18.79M | Capitalization | 24.46M |
---|---|---|---|---|---|
Net income 2024 * | - | Net income 2025 * | - | EV / Sales 2024 * | 1.46 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 1.3 x |
P/E ratio 2024 * |
-35.7
x | P/E ratio 2025 * |
232
x | Employees | 31 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 87.77% |
Latest transcript on Nephros, Inc.
1 day | +4.04% | ||
1 week | +5.94% | ||
Current month | +4.04% | ||
1 month | +5.45% | ||
3 months | -38.62% | ||
6 months | +35.65% | ||
Current year | -32.95% |
Managers | Title | Age | Since |
---|---|---|---|
Robert Banks
CEO | Chief Executive Officer | 49 | 23-03-30 |
Judy Krandel
DFI | Director of Finance/CFO | 59 | Oct. 31 |
Alfred Vargas
COO | Chief Operating Officer | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Arthur Amron
BRD | Director/Board Member | 67 | 07-09-18 |
Oliver Spandow
BRD | Director/Board Member | 52 | 18-08-09 |
Alisa Lask
BRD | Director/Board Member | 53 | 19-02-07 |
Date | Price | Change | Volume |
---|---|---|---|
24-05-01 | 2.32 | +4.04% | 9,016 |
24-04-30 | 2.23 | +0.45% | 16,178 |
24-04-29 | 2.22 | +1.37% | 16,584 |
24-04-26 | 2.19 | 0.00% | 4,904 |
24-04-24 | 2.19 | +2.34% | 7,314 |
Delayed Quote Nasdaq, May 01, 2024 at 04:30 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-32.95% | 24.46M | |
+10.82% | 8.72B | |
+36.64% | 2.17B | |
-8.04% | 1.09B | |
+1.50% | 837M | |
+8.53% | 768M | |
-11.56% | 624M | |
+6.85% | 610M | |
+7.54% | 622M | |
-4.66% | 577M |
- Stock Market
- Equities
- NEPH Stock